Discover the complete record of transactions filed by HANNAH ALISON L., Director. Officer active across 4 companies, notably Neogenomics INC. Cumulatively, 10 disclosures have been recorded. The latest transaction was disclosed on 1 June 2025 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Alison L. Hannah is a Board Member and Chief Medical Officer at NEOGENOMICS INC and RIGEL PHARMACEUTICALS INC. She oversees medical affairs and contributes to the company's strategy. Hannah plays a key role in innovation and the development of new treatments.